Curis Inc (CRIS)

Price$0.52

Value ScoreB

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-63.43%

Price vs S&P 500 (4W)-9.19%

VGM Score35.85

Market Capitalization$20.50M

All Metrics

Book Value / Share (Quarterly)$0.32

P/TBV (Annual)4.90x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.41%

Cash Flow / Share (Quarterly)$-0.72

Price vs S&P 500 (YTD)-53.66%

Gross Margin (TTM)99.52%

Net Profit Margin (TTM)-80.29%

EPS (TTM)$-1.20

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$-1.20

Revenue Growth (5Y)-2.72%

EPS (Annual)$-0.58

ROI (Annual)-138.81%

Gross Margin (Annual)99.52%

Net Profit Margin (5Y Avg)-387.11%

Cash / Share (Quarterly)$0.38

Revenue Growth QoQ (YoY)-65.98%

ROA (Last FY)-37.97%

Revenue Growth TTM (YoY)-36.95%

EBITD / Share (TTM)$-0.44

ROE (5Y Avg)-114.89%

Operating Margin (TTM)-60.50%

Cash Flow / Share (Annual)$-2.10

P/B Ratio1.61x

P/B Ratio (Quarterly)1.72x

Net Income / Employee (Annual)$-315,900

EV / Revenue (TTM)0.58x

Net Interest Coverage (TTM)-177.56x

ROA (TTM)-79.47%

EV / EBITDA (TTM)2.20x

EPS Incl Extra (Annual)$-0.58

Current Ratio (Annual)0.49x

Quick Ratio (Quarterly)1.00x

3-Month Avg Trading Volume0.36M

52-Week Price Return-74.80%

Revenue / Employee (TTM)$294,300

Tangible BV / Share (Quarterly)$69.20

P/S Ratio (Annual)2.17x

Asset Turnover (Annual)0.47x

52-Week High$3.13

Operating Margin (5Y Avg)-371.89%

EPS Excl Extra (Annual)$-0.58

Tangible BV CAGR (5Y)-25.67%

26-Week Price Return-47.50%

Quick Ratio (Annual)0.36x

13-Week Price Return-48.92%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.11x

Enterprise Value$5.49M

Revenue / Share Growth (5Y)-30.62%

Asset Turnover (TTM)0.33x

Book Value / Share Growth (5Y)-51.03%

Revenue / Employee (Annual)$393,500

Inventory Turnover (Annual)0.00x

Pretax Margin (Annual)-80.29%

Cash / Share (Annual)$0.39

3-Month Return Std Dev94.68%

Gross Margin (5Y Avg)97.81%

Net Income / Employee (TTM)$-881,900

ROE (Last FY)-138.81%

Net Interest Coverage (Annual)-9.23x

EPS Basic Excl Extra (Annual)$-0.58

P/FCF (TTM)102.47x

Receivables Turnover (TTM)5.64x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.20

Receivables Turnover (Annual)5.64x

ROI (TTM)-53.31%

P/S Ratio (TTM)2.17x

Pretax Margin (5Y Avg)-387.11%

Revenue / Share (Annual)$0.72

Tangible BV / Share (Annual)$76.00

Price vs S&P 500 (52W)-103.01%

Year-to-Date Return-42.73%

5-Day Price Return13.13%

EPS Normalized (Annual)$-0.58

ROA (5Y Avg)-56.91%

Net Profit Margin (Annual)-80.29%

Month-to-Date Return-5.50%

Cash Flow / Share (TTM)$-9.25

EBITD / Share (Annual)$-0.42

Operating Margin (Annual)-60.50%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-81.88%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.20

P/TBV (Quarterly)1.91x

P/B Ratio (Annual)2.34x

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-80.29%

Book Value / Share (Annual)$0.42

Price vs S&P 500 (13W)-58.66%

Beta3.41x

Revenue / Share (TTM)$0.36

ROE (TTM)-53.31%

52-Week Low$0.46

vGradeB

gGradeF

mGradeD

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-1.25est. -0.41

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.09

4.10

Industry Peers — Biological Products(178)

Symbol	Value Score	Growth Score	Momentum Score	Price
CRISCuris Inc	B	F	D	$0.52
AMGNAmgen Inc	C	C	C	$329.13
GILDGilead Sciences Inc	C	B	C	$131.10
ARGXargenx SE American Depositary Shares	D	A	C	$836.09
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$163.68
BIIBBiogen Inc. Common Stock	B	D	B	$192.23
BNTXBioNTech SE American Depositary Share	C	C	C	$91.70
MRNAModerna, Inc. Common Stock	C	B	B	$46.06
NBIXNeurocrine Biosciences Inc	C	B	B	$161.00
EXELExelixis Inc	C	B	B	$50.28
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$298.10

About

Curis is a biotechnology company developing immuno-oncology and precision oncology therapies targeting solid tumors, diffuse large B-cell lymphoma, and hematological cancers. The company's pipeline includes five drug candidates: Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.